Vulvar Cancer Global Clinical Trials Review, H1, 2012
GlobalData
January 27, 2012 78 Pages - SKU: GBDT6797499
|
|
Vulvar Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2012 provides data on the Vulvar Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vulvar Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vulvar Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
|
- Introduction
- Vulvar Cancer
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Vulvar Cancer
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Vulvar Cancer Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Merck & Co., Inc.
- Clinical Trial Overview of Merck & Co., Inc.
- UMC Utrecht
- Clinical Trial Overview of UMC Utrecht
- Precision Therapeutics, Inc.
- Clinical Trial Overview of Precision Therapeutics, Inc.
- Clinical Trial Overview of Top Universities / Institutes / Hospitals
- Gynecologic Oncology Group
- Clinical Trial Overview of Gynecologic Oncology Group
- The University of Texas M. D. Anderson Cancer Center
- Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
- Leiden University Medical Center
- Clinical Trial Overview of Leiden University Medical Center
- Case Comprehensive Cancer Center
- Clinical Trial Overview of Case Comprehensive Cancer Center
- Northwestern University
- Clinical Trial Overview of Northwestern University
- Memorial Sloan Kettering Cancer Center
- Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
- European Organization for Research and Treatment of Cancer
- Clinical Trial Overview of European Organization for Research and Treatment of Cancer
- University Medical Center Groningen
- Clinical Trial Overview of University Medical Center Groningen
- Masonic Cancer Center
- Clinical Trial Overview of Masonic Cancer Center
- Brigham and Women's Hospital
- Clinical Trial Overview of Brigham and Women's Hospital
- The Christie NHS Foundation Trust
- Clinical Trial Overview of The Christie NHS Foundation Trust
- Centre Oscar Lambret
- Clinical Trial Overview of Centre Oscar Lambret
- Abramson Cancer Center
- Clinical Trial Overview of Abramson Cancer Center
- Erasmus MC
- Clinical Trial Overview of Erasmus MC
- Cardiff University
- Clinical Trial Overview of Cardiff University
- Burzynski Research Institute, Inc.
- Clinical Trial Overview of Burzynski Research Institute, Inc.
- University of Toronto
- Clinical Trial Overview of University of Toronto
- Women and Infants Hospital of Rhode Island
- Clinical Trial Overview of Women and Infants Hospital of Rhode Island
- Dana-Farber Cancer Institute
- Clinical Trial Overview of Dana-Farber Cancer Institute
- Roswell Park Cancer Institute
- Clinical Trial Overview of Roswell Park Cancer Institute
- Five Key Clinical Profiles
- Appendix
- Abbreviations
- Definitions
- Research Methodology
- Secondary Research
- About GlobalData
- Contact Us
- Disclaimer
- Source
- List of Tables
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
- Vulvar Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Vulvar Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
- Vulvar Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The Christie NHS Foundation Trust, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Oscar Lambret, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Women and Infants Hospital of Rhode Island, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
- Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
- List of Figures
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
- Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
- Vulvar Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
- Vulvar Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
- Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
- Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
- Vulvar Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
- GlobalData Methodology
Share this report
Other tasks Related Markets Obstetrics/Gynecology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
